DECEMBER - 20225TECH OUTLOOKCXO INSIGHTSCXO INSIGHTSC O NT E NT SPage - 14Challenges and Opportunities for AI in Drug DiscoveryBobby Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.An Open Innovation Approach Applied to the Pharmaceutical IndustryFederico Piutti,Innovation Manager, Bormioli Pharma16TOP 5 TECH OUTLOOKPHARMA TECHCOMPANIES IN CHINA - 2022New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers Anders Damholt, PhD Biochemistry,Head of Clinical Development Human Health Innovation,CHR. Hansen 18Innovation vs Validation in Early Drug DiscoveryCarlos Pedraza, PhD, Director of CNS Biology, Alkermes1920Real-Life Computer Vision in Manufacturing: All the Things Academy Doesn't Teach YouGuglielmo Iozzia,Associate Director,Business Tech Analysis,MSD Pharmaceuticals22Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]24Pharmaceutical Tablet Coating ­ Past, Present and FutureSteve Brown, Senior Director, EU and APAC Global Manufacturing Science and Technology, Teva Pharmaceuticals [NYSE:TEVA]26Digital InnovationIris Loew-Friedrich, EVP & Chief Medical Officer, UCB28
< Page 4 | Page 6 >